NCT05702177 - A Study of the Effect of Daridorexant on Nighttime Body Posture, the Noise Level Required to Wake up, and the Ability to Remember Words Previously Presented | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

January 5, 2023

Primary Completion Date

April 25, 2023

Study Completion Date

April 25, 2023

Conditions

Healthy

Interventions

DRUG

Daridorexant 25 mg

A single-dose of daridorexant 25 mg will be administered in the evening 30 minutes prior to bedtime.

DRUG

Daridorexant 50 mg

A single-dose of daridorexant 50 mg will be administered in the evening 30 minutes prior to bedtime.

DRUG

Placebo

A single-dose of placebo matching daridorexant will be administered in the evening 30 minutes prior to bedtime.

Trial Locations (1)

Centre for Human Drug Research, Leiden